Rb Capital Management, LLC Astrazeneca PLC Transaction History

Rb Capital Management, LLC

$407 Million
Q3 2024

A detailed history of Rb Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Rb Capital Management, LLC holds 12,268 shares of AZN stock, worth $804,412. This represents 0.23% of its overall portfolio holdings.

Number of Shares

12,268

Previous 12,454 1.49%

Holding current value

$804,412

Previous $971,000 1.65%

% of portfolio

0.23%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$76.67 - $87.62 $14,260 - $16,297	-186 Reduced 1.49%	12,268 $955,000
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $15,700 - $18,995	235 Added 1.92%	12,454 $971,000
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $61 - $69	1 Added 0.01%	12,219 $827,000
Q4 2023 Feb 05, 2024	BUY	$61.89 - $69.28 $928 - $1,039	15 Added 0.12%	12,218 $822,000
Q3 2023 Nov 15, 2023	BUY	$64.85 - $71.7 $3,631 - $4,015	56 Added 0.46%	12,203 $826,000
Q2 2023 Dec 11, 2023	SELL	$69.91 - $75.81 $3,914 - $4,245	-56 Reduced 0.46%	12,147 $869,000
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $1,048 - $1,137	-15 Reduced 0.12%	12,147 $869,000
Q1 2023 May 09, 2023	BUY	$63.15 - $71.6 $7,262 - $8,234	115 Added 0.95%	12,162 $844,000
Q4 2022 Jan 10, 2023	BUY	$54.21 - $70.44 $19,352 - $25,147	357 Added 3.05%	12,047 $817,000
Q3 2022 Oct 21, 2022	BUY	$53.02 - $135.75 $109,433 - $280,188	2,064 Added 21.44%	11,690 $641,000
Q2 2022 Jul 14, 2022	BUY	$59.26 - $71.14 $73,778 - $88,569	1,245 Added 14.86%	9,626 $636,000
Q1 2022 Apr 11, 2022	BUY	$55.72 - $67.12 $8,413 - $10,135	151 Added 1.83%	8,381 $556,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $4,537 - $5,361	84 Added 1.03%	8,230 $479,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $2,778 - $3,039	50 Added 0.62%	8,146 $489,000
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $25,655 - $29,615	544 Added 7.2%	8,096 $403,000
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $18,627 - $21,446	351 Added 4.87%	7,552 $412,000
Q2 2020 Jul 31, 2020	BUY	$43.1 - $55.31 $27,153 - $34,845	630 Added 9.59%	7,201 $381,000
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $174,287 - $236,733	4,612 Added 235.43%	6,571 $288,000
Q4 2019 Feb 11, 2020	SELL	$42.46 - $50.46 $142,410 - $169,242	-3,354 Reduced 63.13%	1,959 $281,000
Q3 2019 Oct 10, 2019	BUY	$40.12 - $45.47 $15,646 - $17,733	390 Added 7.92%	5,313 $231,000
Q2 2019 Aug 07, 2019	SELL	$37.28 - $41.68 $7,567 - $8,461	-203 Reduced 3.96%	4,923 $203,000
Q1 2019 May 08, 2019	BUY	$35.49 - $43.02 $181,921 - $220,520	5,126 New	5,126 $207,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.

Account

Rb Capital Management, LLC Astrazeneca PLC Transaction History